Icon Advisers Inc Biomarin Pharmaceutical Inc Transaction History

Icon Advisers Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$54.08 - $68.32 $378,560 - $478,239	-7,000 Reduced 28.33%	17,706 $973,000
Q1 2025 May 14, 2025	BUY	$61.25 - $72.83 $716,992 - $852,547	11,706 Added 90.05%	24,706 $1.75 Million
Q4 2024 Feb 13, 2025	BUY	$61.93 - $70.49 $805,090 - $916,369	13,000 New	13,000 $854,000

667

182M

1.48M

957K

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $10.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Icon Advisers Inc, based on Form 13F filings with the SEC.

Stay updated on Icon Advisers Inc with notifications on news.